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Case report

Renal artery thrombosis in COVID-19
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COVID-19 has been described to have association with hypercoagulable state and thromboembolic events
in major blood vessels, pulmonary artery, major limb vessels causing limb ischemia. associated with
neurological symptoms and complications including stroke. We present a unique case of renal artery
thrombus formation secondary to COVID-19. To the best of our knowledge this is the fourth manuscript
describing renal artery thrombosis with evidence on imaging studies in medical literature.
© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Case report
A 77-year old female presented to hospital with acute onset of
generalized weakness and two episodes of watery, non-bloody
diarrhea accompanied with poor appetite. She denied fever, chest
pain, shortness of breath, abdominal pain, nausea, vomiting or
urinary complains. Her past medical history included hypothyroidism, stable coronary artery disease, hypertension, chronic
obstructive pulmonary disease, and non-small cell lung carcinoma
in remission. She had a surgical history of abdominal aortic
aneurysmal repair and aortoiliac graft with bilateral renal artery
stenting secondary to renal artery stenosis approximately two
years before. She was hospitalized two weeks previous to
presentation for an endovascular leak which was coiled embolized
successfully by intervention radiology.
Her home medications included amlodipine, metoprolol,
simvastatin, aspirin, tiotropium and levothyroxine. She was a
former smoker with a 40 pack-year smoking history, quitting 16
years before, otherwise no other recreational drug use was
reported. On admission, the vital signs included: blood pressure
90/50 mmHg, heart rate 90, temperature 97.9  F, respiratory rate
normal and oxygen saturation 100 % on room air. Initial laboratory
workup revealed normal white blood cell count of 7000 /mL with
mild lymphopenia, with hemoglobin 11.0 g/dL and platelet count of
305,000/mL. The chemistry panel was noted to be unremarkable
without transaminitis. The inﬂammatory markers at the time of
admission are summarized in Table 1.
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The patient had a nasal swab for COVID-19 which resulted
positive. Due to her acute generalized weakness and hypotension
in the setting of recent aortic intervention, there was a suspicion
for recurrent endovascular leak. Therefore, computed tomographic
(CT) angiography with dissection protocol was obtained. The CT
scan study ruled out any retroperitoneal bleeding or signiﬁcant
aortic structural defect but revealed intraluminal ﬁlling defects
compatible with thrombus within renal artery stents bilaterally.
After hemodynamically optimizing the patient she was
evaluated by the interventional radiology and vascular surgery
teams. A renal duplex scan was subsequently perform showing no
signiﬁcant stenosis in right renal artery and but occlusion of the
left renal artery. The patient’s blood pressure and renal function
remained intact throughout the hospital stay. It was determined
from imaging studies that the anatomical location of the thrombus
was not amenable to any intervention. Secondarily, given the
history of aortic aneurysmal repair, any other intervention was
deemed inappropriate as it may likely do more harm than beneﬁt
as the patient remained asymptomatic.
The hypercoagulable studies were performed to screen for
prothrombotic diseases which were negative. It was concluded
that the patient’s renal artery thrombosis was caused by the
hypercoagulable state induced by COVID-19. The patient continues
to follow up outpatient with her primary care physician and
nephrology.
Discussion
Since the emergence of global pandemic of the novel
coronavirus (COVID-19) in China in December 2019, it has been
described as a causative agent for spectrum of clinical pathologies

https://doi.org/10.1016/j.idcr.2020.e00968
2214-2509/© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

S. Acharya, S. Anwar, F.S. Siddiqui et al.

IDCases 22 (2020) e00968

Table 1
INFLAMMATORY MARKERS.
MARKERS

RESULTS

C-reactive Protein
Ferritin
Procalcitonin
Lactate dehydrogenase
D-dimers
Prothrombin time/INR
Activate partial thromboplastin time

5.55 mg/dL
589 ng/mL
0.13 ng/mL
583
4620 ng/mL
11.6/1.01
29
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(acute respiratory distress syndrome, shock, multi-organ failure).
Clinical practice and data have suggested that COVID-19 is
producing severe hypercoagulability state in patients leading to
both venous and arterial thromboembolic events such as pulmonary embolism, stroke and limb ischemia [1–4].
The effect of covid-19 infection on renal function is not clearly
determined and more studies are underway to describe the
pathophysiology [5]. With this brief literature review, kidney
dysfunction seen in COVID-19 patient can partly be described with
undetected renal artery thrombosis and systemic microangiopathies with renal microthrombi [6–8]. Our patient described above
presented with an incidental ﬁnding of thrombus formation in
renal artery stenting. Patient has been asymptomatic with no
changes in the urine production. The decision for intervention with
revascularization mainly depends upon the size of the vessel
involved, time of onset and size of infarction. The success of such
intervention is unpredictable, and the patient may become
dependent on renal replacement therapy if there is not enough
renal reserve left as described by Philipponnet [6]. The timeline of
renal artery thrombosis and renal infarcts may not necessarily
align, and signs and symptoms may present after signiﬁcant
interval with possible no evidence of thromboembolism [9,10].
Although, not enough data is available, but antiplatelets or full
anticoagulation should be considered in patients with diagnosed
renal infarcts. As our patient had a signiﬁcant risk of endovascular
bleed due to recent abdominal aortic aneurysmal repair, it was
decided to hold off with anticoagulation.
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Conclusion
This article and literature review summarize the cases
described with renal artery thromboembolism and infarcts
secondary to thromboembolic state induced by COVID-19 infection. This limited data suggests that such macro and microthromboembolic activities may have played role in causing renal
dysfunction seen with COVID-19 infections. Further studies are
required to determine role of revascularization or long-term
anticoagulation for treatment modalities.
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